Tag Archives | New England Journal of Medicine

new drug dificid for c difficile

Biotech Firm Wins FDA Approval for C. Difficile Antibiotic

The number of newly approved antibiotics has declined significantly since the 1980s as large pharmaceutical companies have mostly withdrawn from research and development in this critical market segment. Fortunately, the biotech industry is now stepping up to the plate to develop much-needed antibiotics to fight a rising number of drug-resistant superbugs, such as Clostridium difficile (or C. […]

Read full story · Comments { 0 }

Tags: , , , , , , , ,

atrial fibrillation

Designer Drugs for Atrial Fibrillation Patients

Three new game-changing anticoagulants have been developed for the prevention of strokes in people with atrial fibrillation. The new designer drugs dabigatran, rivaroxaban and apixaban offer significant benefits compared to decades-old warfarin, but there are some downsides to consider. More than 2.7 million Americans have atrial fibrillation today and an estimated 12 million may have […]

Read full story · Comments { 2 }

Tags: , , , , , , , , , , , , , , , ,

the anti-diet winning the war on obesity

Best Strategies for Maintaining Long-Term Weight Loss

Do you wonder why, after losing weight last year, you’re back to where you started? Are you telling yourself that this time, you will strengthen your resolve and make it stick? A surprising new Australian study helps explain that your lack of willpower may not be to blame. Published recently in the New England Journal […]

Read full story · Comments { 5 }

Tags: , , , , , , , , , , , ,